PATRICK M. FLATLEY, Bankruptcy Judge.
Protea Biosciences Inc., and Protea Biosciences Group, Inc. (collectively, "Protea"), object to an unsecured proof of claim filed by Laidlaw & Company (UK) Ltd. ("Laidlaw"), in the amount of $380,000 and to an unsecured proof of claim filed by PPLL Partners, LLC ("PPLL") in the amount of $360,000. Protea also requests that both unsecured claims be recharacterized as capital contributions. Laidlaw and PPLL move to dismiss the objection and request for recharacterization on the grounds that: (1) a request for recharacterization requires an adversary proceeding; (2) Protea improperly objected to two claims in a single document; and (3) any objection is premature until it can be ascertained that a dividend will be payable to unsecured creditors in Protea's bankruptcy case.
For the reasons stated herein, the court will deny Laidlaw's and PPLL's motion to dismiss and set a scheduling conference regarding Protea's objection to claims and request for recharacterization.
Laidlaw and PPLL seek to dismiss Protea's objection to claim pursuant to Fed. R. Civ. P. 12(b), which is made applicable to bankruptcy adversary proceedings under Fed. R. Bankr. P. 7012.
An objection to a proof of claim, however, is treated as a contested matter. 9 Collier on Bankruptcy ¶ 3007.01 (2018). Once a contested matter is initiated, many of the rules governing adversary proceedings automatically apply; however, Fed. R. Bankr. P. 9014(c) does not make Fed. R. Bank. P. 7012 applicable to contested matters. Consequently, unless specifically ordered by the court on notice to the parties, there is no motion to dismiss a contested matter that is governed by the Fed. R. Civ. P. 12(b). Laidlaw and PPLL have asserted an inapplicable motion in response to Protea's objection to their claims.
Nevertheless, the court will adjudicate Laidlaw's and PPLL's preliminary response to Protea's claims objection under Fed. R. Bankr. P. 3007(b), which states that "[a] party in interest shall not include a demand for relief of a kind specified in Rule 7001 in an objection to the allowance of a claim, but may include the objection in an adversary proceeding," and Fed. R. Bankr. P. 3007(c), which generally prohibits multiple objections to proofs of claim being filed in a single document.
According to a Declaration filed by Protea in this case on December 2, 2017, it is a publicly traded Delaware Corporation that uses mass spectrometry imaging to provide bioanalytical services to the healthcare industry. Its lab provides services to major pharmaceutical, chemical, and biotechnology companies to identify and quantify biologically active molecules in living cells and tissue samples.
According to Protea's objection to claims, Laidlaw represented that Laidlaw could use Laidlaw's business contacts at Massachusetts General Hospital ("Mass General") to facilitate a joint venture or close working relationship between Mass General and Protea. More specifically, Protea was to work with Mass General's Vaccine and Immunotherapy Center to develop a diagnostic methodology for obtaining cancer cell molecular profiles, including the distribution of drugs with cancer cells and molecular response indicators (the "Collaboration Agreement").
Before entering the Collaboration Agreement, however, Protea states that Mass General required a $360,000 fee. Because Protea did not have the funds available to make that payment, the principals of Laidlaw offered to make a loan of $360,000 to Protea through PPLL. Instead of directly loaning the money to Protea, PPLL was to make payments required by the Collaboration Agreement to Mass General.
In contrast, PPLL states that its $360,000 claim is based on both the execution of the Collaboration Agreement with Mass General and PPLL's Services Agreement with Protea. Exhibit C to the Service Agreement is a Non-Negotiable Convertible Promissory Note in the amount of $360,000
Laidlaw states that it made loans to Protea by wire transfers on October 3, 4, and 5, 2017 in the amount of $100,000.00, $10,000.00, and $150,000.00, and that it is owed a $120,000.00 "fee for placing Wawrla loan." (Case No. 17-bk-1201, Claim No. 18-1, p. 4), for a total claim of $380,000.00. Only one note, however, is attached to Laidlaw's proof of claim. That note is dated October 3, 2017, and it provides an acknowledgement by Protea for the receipt of $110,000. The "fee for placing the Wawrla loan" relates to an Engagement Agreement whereby Laidlaw agreed to place securities in Protea.
PPLL and Laidlaw jointly assert that a request for recharacterization of a claim requires Protea to file an adversary proceeding. They also assert that Protea has improperly combined an objection to two different proofs of claim in a single document and that Protea's objection is premature.
Laidlaw and PPLL argue that Protea's effort to recharacterize their asserted unsecured claims into capital contributions requires an adversary proceeding under Fed. R. Bankr. P. 3007(b) and 7001(2), (7), and/or (8). On this basis, they contend that the court lacks subject matter jurisdiction and they have received improper process or improper service of process.
A bankruptcy court's subject matter jurisdiction derives from 28 U.S.C. § 1334. That statute grants district courts original and exclusive jurisdiction over all bankruptcy cases commenced under title 11 of the United States Code, and original but not exclusive jurisdiction over all civil proceedings arising under, arising in, or related to a case under title 11. By order of reference last amended on April 2, 2013, this grant of bankruptcy jurisdiction was referred to this bankruptcy court.
Because Laidlaw and PPLL have submitted proofs of claim in Protea's bankruptcy case, and because Protea has objected to those proofs of claim under Fed. R. Bankr. P. 3007, this is an action that arises in or under title 11, and this court has subject matter jurisdiction to hear and determine Protea's objection to claims. Adjudicating a claim for recharacterization in an objection to a proof of claim is not issue of subject matter jurisdiction; rather, it is an issue that concerns the appropriate form of the bankruptcy proceeding.
A request for recharacterization, which is often filed in conjunction with other causes of action that fall within the scope of Fed. R. Bankr. P. 7001, may be adjudicated through an adversary proceeding. See, e.g., Highland Constr. Mgmt. Servs., LP v. Wells Fargo (In re Highland Constr. Mgmt. Servs., LP), 569 B.R. 673 (E.D. Va. 2017) (noting that Count I of the adversary complaint was for recharacterization and Count II was for equitable subordination).
Fed. R. Bankr. P. 7001(8) specifically states, with some exceptions, that "a proceeding to subordinate any allowed claim or interest" is an adversary proceeding.
Recharacterization and subordination, however, are different. "Subordination is a remedy in which the order of payment rather than the existence of the debt is in issue." 4 Collier on Bankruptcy ¶ 510.02[1] (2018). Subordination is often based on creditor misconduct such as fraud or usury. Id. In contrast, recharacterization generally occurs when a party asserts that a loan was made but the original circumstances of the loan compels treating the advance not as debt but as equity. Id. at [3]. Thus, "[r]echaracterization cases turn on whether a debt actually exists,
Consequently, a request for recharacterization does not fall within the scope of Fed. R. Bankr. P. 7001(8) because recharacterization seeks a determination as to the claim's proper classification in the Bankruptcy Code and does not seek the subordination of a valid claim based on inequitable conduct.
Similarly, a request for recharacterization of a debt, which is represented by a proof of claim, to a capital contribution, which is generally represented by a proof of interest, is not a proceeding to obtain an "injunction or other equitable relief" as provided in Fed. R. Bankr. P. 7001(7). The term "other equitable relief" generally includes accountings, specific performance, marshalling, constructive trusts, and orders to compel compliance with state law. E.g., 10 Collier on Bankruptcy ¶ 7001.08 (2018) (listing types of "other equitable relief"). A request to properly and originally classify the existence of a claim or interest against a bankruptcy estate is not consistent with the with the nature of an injunction or other equitable relief as contemplated by Fed. R. Bankr. P. 7001(7).
Laidlaw's and PPLL's reliance on Fed. R. Bankr. P. 7001(2) is also improper. More specifically, Rule 7001(2) is for proceedings "to determine the validity, priority or extent of a lien or other interest in property. . . ." Here, neither Laidlaw nor PPLL have asserted any lien in property. The last phrase of Rule 7001(2), "other interest in property," can refer to a dispute over the ownership of stock in a debtor. 10 Collier on Bankruptcy ¶ 7001.03[3] (2018). In this case, however, there is no dispute between the parties over ownership of Protea's stock. Instead, the dispute is whether Laidlaw's and PPLL's asserted claims, to the extent those claims exist, are actually capital contributions. See generally In re Micro-Precision Technologies, Inc., 303 B.R. 238, 243 (Bankr. D.N.H. 2003) (finding that a request to recharacterize a debt claim as a capital contribution "is not a type of action listed in Rule 7001 that must be brought as an adversary proceeding"); In re 431 W. Ponce De Leon, LLC, 515 B.R. 660, 674 (Bankr. N.D. Ga. 2014) ("While the recharacterization of debt has typically been addressed in the Eleventh Circuit through an adversary proceeding, there is no rule requiring such."); Algonquin Power Income Fund v. Ridgewood Heights, Inc. (In re Franklin Indus. Complex, Inc.), 2007 Bankr. LEXIS 3004, at *45 n. 17 (Bankr. N.D.N.Y. Aug. 30, 2007) ("Plaintiffs' request for recharacterization of the Defendants' claims does not require the commencement of an adversary proceeding pursuant to Fed. R. Bankr. P. 7001.").
Therefore, the court finds no merit in Laidlaw's and PPLL's contention that a request for recharacterization of an unsecured debt to a capital contribution requires an adversary proceeding under Fed. R. Bankr. P. 3007(b) and 7001(2), (7), and/or (8).
Laidlaw and PPLL assert that Protea improperly combined its objection against Laidlaw's claim and its objection to PPLL's claim in a single document. Under Fed. R. Bankr. P. 3007(c), "unless otherwise ordered by the court . . . objections to more than one claim shall not be joined in a single objection."
Rule 3007(c) does not specify the method by which a court may order more than one claim to be joined in a single objection. In Protea's opposition to Laidlaw's and PPLL's motion to dismiss, it specifically requests the court enter an order allowing it to object to both claims in a single objection on the basis that Laidlaw and PPLL are related entities, with the same counsel, and both entities were, at least in part, involved with Protea's business relationship with Mass General. According to 9 Collier on Bankruptcy ¶ 3007.03 (2018), the court should consider whether the claimants will receive "fair notice of any objection" when determining whether to allow an objection to more than one claim in a single document.
The court will allow Protea to combine its objection to both Laidlaw's and PPLL's proofs of claim in a single claims objection for the reasons set forth by Protea, and because both Laidlaw and PPLL are fully aware of Protea's objection to their claims.
Laidlaw and PPLL assert that Protea's bankruptcy estate is administratively insolvent; thus, no purpose is served by objecting to their unsecured claim until such time as there might be a return to unsecured creditors.
Protea asserts that its bankruptcy case is administratively solvent and, pursuant to a plan, there will be a return to unsecured creditors and a litigation trust whereby further causes of action might be pursued that could bring value to the bankruptcy estate. Protea also references a contemplated sale that it estimates will bring about $1 million into the bankruptcy estate.
The court notes that as of the date of this Memorandum Opinion, there are $632,424.50 in professional fee applications. On this basis, and in light of a pending sale motion, the Court finds that Protea's objection to claims is not premature.
Based on the reasons set forth above in the court's Memorandum Opinion, it is